C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,000 | +1000.0% | 5,804 | +936.4% | 0.00% | – |
| Q2 2023 | $1,000 | -88.9% | 560 | -80.9% | 0.00% | – |
| Q1 2023 | $9,000 | -81.6% | 2,933 | -64.6% | 0.00% | – |
| Q4 2022 | $49,000 | +444.4% | 8,286 | +683.9% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 1,057 | +35.5% | 0.00% | – |
| Q2 2022 | $6,000 | -90.0% | 780 | -68.2% | 0.00% | – |
| Q1 2022 | $60,000 | -83.7% | 2,456 | -78.6% | 0.00% | – |
| Q4 2021 | $369,000 | +8.2% | 11,475 | +50.5% | 0.00% | – |
| Q3 2021 | $341,000 | +74.0% | 7,625 | +47.3% | 0.00% | – |
| Q2 2021 | $196,000 | +493.9% | 5,177 | +472.0% | 0.00% | – |
| Q1 2021 | $33,000 | -2.9% | 905 | -11.5% | 0.00% | – |
| Q4 2020 | $34,000 | – | 1,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |